Tilray CEO on Grow Deal, Aphria Merger, Pot Legalization

Feb.09 — Tilray CEO Brendan Kennedy discusses the pact with Grow Pharma to distribute Tilray’s medical cannabis products in the U.K., the agreed merger with Aphria, and the outlook for U.S. legalization of marijuana on “Bloomberg Markets: The Close.”

Leave a comment

Your email address will not be published. Required fields are marked *